Julia Stieglmaier

Julia Stieglmaier

UNVERIFIED PROFILE

Are you Julia Stieglmaier?   Register this Author

Register author
Julia Stieglmaier

Julia Stieglmaier

Publications by authors named "Julia Stieglmaier"

Are you Julia Stieglmaier?   Register this Author

9Publications

372Reads

46Profile Views

Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer.

Expert Opin Biol Ther 2015 13;15(8):1093-9. Epub 2015 May 13.

Amgen Research (Munich), Global Clinical Development, Therapeutic Area Oncology , Staffelseestraße 2, Munich 81477 , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.1041373DOI Listing
February 2016

Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.

Cancer Immunol Immunother 2008 Feb 31;57(2):233-46. Epub 2007 Jul 31.

Chair of Genetics, University of Erlangen-Nuremberg, BTE-Building, Erwin-Rommel-Strasse 3, 91058 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-007-0370-8DOI Listing
February 2008

Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists.

Cancer Res 2008 Jan;68(2):597-604

Groningen University Institute for Drug Exploration, Department of Pathology and Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-07-5171DOI Listing
January 2008